NCT05317260View on ClinicalTrials.gov

Steatohepatitis in Chronic Hepatitis B

CompletedOBSERVATIONAL
Enrollment

408

Participants

Timeline

Start Date

January 1, 2002

Primary Completion Date

December 31, 2020

Study Completion Date

December 31, 2021

Conditions
Fatty LiverChronic Hepatitis b
Interventions
DRUG

Antiviral Agents

The type of antiviral agents for the individual patient was selected by physicians based on a policy to reimburse a patient's health and comorbidity.

Trial Locations (1)

10700

Faculty of Medicine Siriraj Hospital, Bangkoknoi

All Listed Sponsors
lead

Mahidol University

OTHER

NCT05317260 - Steatohepatitis in Chronic Hepatitis B | Biotech Hunter | Biotech Hunter